Washington, D.C., (December 4, 2018) —MedStar Heart in partnership with CardioCell has been approved to conduct an investigational new drug clinical trial, called STEMVAD at MedStar Heart & Vascular Institute. The goal of this study is to determine whether stem cell therapy improves myocardial function in patients with severe heart failure. “Innovative therapies to improve heart function and outcomes of patients with advanced heart failure are sorely needed,” said Selma Mohammed, MD, PhD. Read more.
Recent Posts
- COVID-19 Community Research Partnership: MedStar Health Data
Thank you to all current participants in the study! Below you will find some data about the curr... - Investigation of COVID-19 Positive Test Prior to Elective Surgeries Published from MedStar Health Team
Researchers from MedStar Health Urgent Care/MedStar Ambulatory Services, MedStar Health Research Ins... - MedStar Health Measures Goal-Based Outcomes Among Older Disabled Patients
Collaborative research from MedStar Health Research Institute’s Health Economics and Aging Researc...
Contact
Eva Hochberger
Communications & Planning Manager
Phone: 301-560-2917
[email protected]